Skip to main content

‘marijuana’

How U.S. Attorneys Have Responded to the Rescission of Marijuana Enforcement Guidance

Jan. 13, 2018—[Revised 1/14 for clarity and updates.] Now that the Attorney General has rescinded Obama-era marijuana enforcement guidance, local federal prosecutors (U.S. Attorneys) arguably have more leeway to pursue legal action against the state-licensed recreational marijuana industry. (The state-licensed medical marijuana industry is still protected by spending restrictions Congress has imposed on the DOJ, at least under the current federal budget .)...

Read more


Call for Papers on the Economics of Marijuana and Drug Policy

Dec. 30, 2017—Economic Inquiry, a peer-reviewed economics journal, has issued a call for papers on the economics of marijuana and drug policy. Submissions are due March 1, 2018. Interested authors can find out more about the CFP here.

Read more


Is Small Marijuana Doomed?

Dec. 29, 2017—FiveThirtyEight has just published an article detailing some interesting trends in the marijuana market in Washington state. I found two statistics particularly striking. First, the average retail price of a gram of flower has dropped 77 percent from July 2014 to December 2017. The average price is now $7.45 versus $32.48 when stores first opened...

Read more


Cases to Watch: Lawsuit Challenges Florida Restriction on Smokable Marijuana

Dec. 20, 2017—In fall 2016, Florida voters approved an initiative (Amendment 2) to legalize the “medical use” of marijuana. In June 2017, the Florida legislature passed a bill to implement Amendment 2. One provision of that bill defined permissible “medical use” to exclude the use of marijuana “in a form for smoking . . .” Fla. Stat....

Read more


Cases to Watch: Applicant Sues to Block Ohio from Using Racial Preferences in the Award of Commercial Marijuana Licenses

Dec. 15, 2017—In the book, I discuss the lack of racial diversity in the state-licensed commercial marijuana industry, as well as the measures states have adopted to boost minority participation in that industry (pages 454, 520-25). There are several steps states could take to improve diversity, but one of the most direct is to employ some form...

Read more


It’s Getting Easier for Marijuana Companies to Open Bank Accounts

Dec. 6, 2017—Stateline has a nice article today (posted here) suggesting that marijuana suppliers are increasingly able to obtain financial services from banks and credit unions. The article notes that as of June 2017, roughly 400 banks and credit unions reported providing services to marijuana-related businesses. It suggests that some states (like Washington) have facilitated access by helping these banks comply with the Treasury...

Read more


Massachusetts Medical Society Launches New Cannabis Curriculum

Dec. 4, 2017—As I discussed in this earlier post and in the book (pages 616-618), many physicians remain reluctant to recommend marijuana to their patients because they never received training concerning the drug. To remedy that lack of training, the Massachusetts Medical Society has just launched an interesting new Cannabis Curriculum for Continuing Medical Education. The Society’s website describes...

Read more


Do (Should) State Marijuana Reforms Apply Retroactively?

Dec. 2, 2017—Suppose that Danica violates her state’s marijuana prohibition. If the state later repeals that prohibition, does (and should) the repeal apply retroactively to Danica’s offense? To date, most states have failed to explicitly address this question. But California and Colorado have recently begun offering relief for some marijuana offenses that pre-date their respective reforms. California’s...

Read more


Caveat Emptor: Are Marijuana Labels Accurate?

Nov. 15, 2017—As discussed in the book, many legalization states have adopted detailed labeling requirements for marijuana products (see pages 456-462). Among other things, suppliers must clearly indicate the quantity of THC and CBD contained in packages of marijuana. Labeling requirements like these are designed to inform consumers and thereby help them make better consumption choices. To...

Read more


What’s the Point of Rescheduling Marijuana in a Medical Marijuana State?

Nov. 1, 2017—A number of sites have reported on Kadonsky v. Lee, in which a New Jersey appellate court just ordered a state official to consider rescheduling marijuana under the state’s Controlled Dangerous Substances Act (CDSA). New Jersey’s CDSA is virtually identical to the federal Controlled Substances Act (CSA). Marijuana remains a Schedule I controlled substance under...

Read more